Home      About this journal      Authors      Referees      Editors      Readers      Archive      Contact us
Angiogenic effect of bone marrow mesenchyma stem cells transplantation intervened by SalB on acute myocardial infarcts in rats infarction in rats
Hits 1432  Download times 1812  Received:June 12, 2007  
View Full Text  View/Add Comment  Download reader
DOI   10.11656/j.issn.1673-9043.2007.03.10
Key Words   Salvianolic acid B;MSCs;ischemic heart disease;cell therapy;angiogenesis
Author NameAffiliation
FAN Ying-chang Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China 
HUA Sheng-yu Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China 
GUO Mao-juan Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China 
徐秀梅 Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China 
Abstract
    [Objective] To evaluate the angiogenic effect of the bone marrow mesenchymal stem cells (MSCs) transfected with SalB on myocardial infarcts in rats[Methods] The animal model of heart ischemic was established by ligating the left anterior descending coronary artery in Wistar rats.The ligated rats were divided into 5 groups (n=15each),and they were injected MSC at the heart infarct zone with SalB (Group SalB+B),MSCs (Group B),SalB (Group SalB),sham operation (Group S) and model.Two weeks after the injection,the capillary density of the infracted zone and the expression of CD34 in vivo were examined.[Results] Two weeks after the transplantation,the capillary density was significantly greater in Group SalB+B than that in Group B and Group SalB.[Conclusion] Bone marrow mesenchyma stem cells interfered with SalB on myocardial infarcts in rats could provide the blood of infarction zone and maybe form new vasculars to repair infracted myocardium,and SalB is one of the important material basal in Danshen and have satisfactory development and application prospect.

You are the 1618915 visitor.

Copyright @ 2007
Address:   Postcode:
Tel:  Fax:  E-mail:
Beijing E-Tiller Co., Ltd.